RCEL
RCEL
NASDAQ · Biotechnology

Avita Medical Inc

$4.13
-0.12 (-2.82%)
As of Jun 30, 10:31 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +738.0% upside
Low Target $23.82
Average Target $34.61
High Target $34.97
Current Price $4.13
Current
$4.13
Target
$34.61
$23.82 $34.61 avg $34.97
Scenario Analysis
Bear Case
$23.82
476.8%
Low target
Base Case
$34.61
+738.0%
Avg target
Bull Case
$34.97
+746.7%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$7.12
-42.0% from high
52-Week Low
$3.22
+28.3% from low
Target vs 52W High
$34.61
+386.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%